1-4 of 4
Keywords: prostate
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Clin Sci (Lond) (2018) 132 (20): 2189–2205.
Published: 19 October 2018
...Ping Chen; De-qiang Xu; Sheng-li Xu; He Xiao; Sheng-hong Wan; Xing-huan Wang; Michael E. DiSanto; Xin-hua Zhang To investigate the effect of blebbistatin (BLEB, a selective myosin inhibitor) on regulating contractility and growth of prostate cells and to provide insight into possible mechanisms...
Includes: Supplementary data
Articles
Clin Sci (Lond) (2005) 108 (4): 293–308.
Published: 22 March 2005
...Daniel GIOELI Prostate cancer is the most frequently diagnosed cancer among men and the second leading cause of male cancer deaths in the United States. When prostate cancer initially presents in the clinic, the tumour is dependent on androgen for growth and, therefore, responsive to the surgical...
Articles
Clin Sci (Lond) (2002) 103 (s2002): 314S–317S.
Published: 01 September 2002
...Badar A. USMANI; Ben HARDEN; Norman J. MAITLAND; Anthony J. TURNER Neutral endopeptidase-24.11 (neprilysin; NEP/CD10) is a cell surface metallopeptidase expressed by prostatic epithelial cells that degrades various bioactive peptides including endothelin. Endothelin-converting enzyme (ECE), the key...
Articles
Clin Sci (Lond) (2002) 103 (s2002): 442S–445S.
Published: 01 September 2002
... refractory prostate cancer who have undergone aggressive hormone ablation therapy. It is not known how hormone ablation affects ET-binding sites, although ET-1 and ET A expression are found to be elevated in prostate cancer patients. In this study, we examined the effect of castration on ET receptor binding...